Publications

  1. Hudnall SD, Kurbe M.  Cyclosporin A induced inhibition of EBV lymphoblastoid cell regression: Reversal by rIL2. 6th Intl Congress of Immunology, July 1986.
  2. Hudnall SD, Kurbe M.  Role of antigen nonspecific effectors in the reversal of cyclosporin A induced inhibition of EBV-B cell cytotoxicity by rIL2 and gamma interferon.  2nd International EBV Conference, St. Petersburg Beach, FL, October 1986.
  3. Hudnall SD, Kurbe M.  Role of CD8+ and CD8- cytolytic effectors in IL2 reversal of cyclosporin-inhibited EBV-B cell cytotoxicity.  In: Epstein-Barr Virus and Human Disease (eds) Levine PH, Ablashi DV, Pearson GR, Kottaridis SD. (Humana, New Jersey) 1987.
  4. Park NH, Paik DI, Hudnall SD.  Three cell lines derived from herpes simplex virus and 7,12-dimethylbenzanthracene-induced tumors in hamster buccal pouches and skin.  Intl Association of Dental Research, 1988.
  5. Hudnall SD, Glaspy J, Naeim F.  Treatment of hairy cell leukemia with alpha and beta interferon: Comparison of hematopathologic changes. US-Can Acad Path, Feb 1988.
  6. Hernandez-Jodra M, Petz LD, Hudnall SD.  RBC autoantibody production in lymphocyte cultures.  Intl Society for Blood Transfusion, London England, July 1988.
  7. Hernandez-Jodra M, Petz LD, Hudnall SD.  RBC autoantibody production in lymphocyte cultures.  American Society of Hematology, San Antonio TX, Dec 1988.
  8. Hudnall SD, Blaesing LS, Koerner TAW.  Transformation-induced glycosphingolipid expression in human B lymphocytes.  American Society of Biochemistry & Molecular Biology, San Francisco CA, Jan 1989.
  9. Hudnall SD, Berenson J.  Evidence of a clonal isotype switch within the pseudofollicular proliferation center of a small lymphocytic lymphoma: implications regarding the origin of proliferation centers.  US-Can Academy of Pathology, Boston MA, March 1990.
  10. Yeghiayan P, Brownfield E, and Hudnall SD.  Detection of EBV nucleic acid in human tissue by a nonradioactive method.  4th National Conference for Undergraduate Research, Schenectady NY, April 1990.
  11. Hudnall SD, Zeidler M.  Propagation and EBV infection of primary epithelial cells derived from human tonsil and adenoid.  4th Intl EBV Conference, Taiwan, Sept 1990.
  12. Hudnall SD, D Chou, Abbas A.  Lymphokine reversal of the CSA mediate EBV LCL regression defect:  Implications for the pathogenesis of post-transplant LPD. American Society of Hematology, Nov 1990.
  13. Hudnall SD,  Repinski C,  Buckley C, Naeim F.  Flow cytometric immunophenotypic of 50 normal human bone marrows:  determination of 33 normal reference ranges.  Clinical Cytometry Society, Charleston SC, Sept 1991.
  14. Hudnall SD, Cheng L, Susi E, Gordy W, Kobashigawa J.  Anaplastic regressing EBV-positive composite B/T cell post-transplant lymphoma.  US-Can Academy of Pathology, Atlanta GA, March 1992.
  15. Chucrallah AE, M Crowe, Hudnall SD. Multiple myeloma following cardiac transplantation: an unusual form of post-transplant lymphoproliferative disease.  Texas Society of Pathologists, Houston TX, Feb 1993.
  16. Conway J, R Brown, SD Hudnall.  Superiority of EBER1 In-situ hybridization to EBV LMP immunostaining and EBNA1 PCR for detection of EBV from formalin-fixed paraffin-embedded tissue.  US-Can Acad Pathology, San Francisco CA, March 1994.
  17. Hudnall SD, J Conway, JT Manning, BM Osborne.  Multiparametric analysis of Epstein-Barr virus in composite non-Hodgkins / Hodgkins lymphoma.  US-Can Academy of Pathology, San Francisco CA, March 1994.
  18. Hudnall SD, M Grey, YD Li. Detection and immunophenotype of EBV infected cells by a rapid two color immuno-in situ hybridization flow cytometric technique. 7th Intl EBV Conference, Cold Spring Harbor NY, Sept 1994.
  19. Imbing  F, Haque AK, Gelman B, Hudnall SD. Pulmonary lymphoproliferative lesions in AIDS: an association with EBV.  US-Can Academy of Pathology, Toronto, March 1995.
  20. Luthringer DJ, Yamashita J, Fishbein MC, Hudnall SD. Epicardial lymphoid infiltrates in cardiac allografts are not Epstein-Barr virus associated. US-Can Academy of Pathology, Toronto, March 1995.
  21. Hudnall SD,  Conway J, Lazarides A, Bahler A,  Li YD, Osborne B. Epstein Barr virus positive Reed-Sternberg like cells in infectious mononucleosis associated lymphadenopathy.  US-Can Academy of Pathology, Toronto, March 1995.
  22. Hudnall SD, Elghetany MT, Patel J.  The flow immunophenotypic profile of atypical lymphocytosis. Clinical Cytometry Society. Charleston SC, Sept 1995.        
  23. Hudnall SD, Sellers R, Yen A, Rady PL, Tyring SK.  Detection of Kaposi’s sarcoma and post-transplant squamous lesions: Evidence for infection of both Kaposi’s sarcoma tissue and squamous epithelium.  US-Can Acad Pathol, Washington DC, March 1995.
  24. Elghetany MT, Hudnall SD, Gardner FH.  Aplastic anemia and primary hypoplastic refractory anemia: Discrimination using peripheral blood morphologic findings prior to immunotherapy. US-Can Academy of Pathology, Washington DC, March 1995.
  25. Yen A, Rady PL, Hudnall SD, Sellers R, Wagner R, Orengo I, Bruce S, Tyring SK. Prevalence of human herpesvirus 8 DNA in Kaposi’s sarcoma, carcinomas, and post-transplant squamous. Society for Investigative Dermatology. 1995.
  26. Yen A, Rady PL, Hudnall SD, Sellers R, Wagner R, Orengo I, Bruce S, Tyring SK. Prevalence of HHV-S in cutaneous sarcomas and carcinomas.  National Student Research Forum, Galveston TX, 1995.
  27. Wilcox GE, Hudnall SD, Gondo M, Stephenson M, Spjut H, Cagle PT. p53 expression in papillary adenocarcinomas of the lung. US-Can Academy of Pathology, Washington DC, March 1995.
  1. Rady P, Hudnall SD, Hodak E, Trattner A, Feinmesser M, David M, Sellers R, Yen A, Memar O, Tyring SK.  Presence of human herpesvirus 8 DNA in Kaposi’s sarcoma from patients treated with corticosteroids.  Intl AIDS Malignancy Conf, Bethesda MD, May 1996.
  2. Rady PL, Hudnall SD, Hodak E, Trattner A, Feinmesser M, David M, Sellers R, Yen A, Memar O, Tyring S.  HHV-8 DNA in Kaposi’s sarcomas from patients treated with corticosteroids.  Institute for Human Virology, Baltimore MD, May 1996.
  3. Rady PL, Hudnall SD, Hodak E, Trattner A, Feinmesser M, David M, Sellers R, Yen A, Memar O, Tyring SK. Presence of HHV-8 in Kaposi’s sarcomas from iatrogenically immunosuppressed patients. 1st Conf Intl Moritz Kaposi Research Foundation, Budapest, Hungary. Aug 1996.
  4. Hudnall SD, Sellers R, Yen A, Orengo I, Bruce S, Rady PL, Tyring SK.  In-situ detection of Kaposi’s sarcoma associated herpesvirus (HHV-8) DNA in Kaposi’s sarcoma skin biopsies. Institute for Human Virology, Baltimore MD, Sept 1996.
  5. Vyas S, Youh G, Hudnall SD, Elghetany MT. p53 expression in marrow biopsies from patients with hypercellular refractory anemia, hypocellular refractory anemia and aplastic anemia.  Texas Society of Pathologists, Corpus Christi, TX, Jan 1997.
  6. Vyas S, Youh G, Hudnall SD, Elghetany MT. p53 expression in marrow biopsies from patients with hypercellular refractory anemia, hypocellular refractory anemia and aplastic anemia. US-Can Academy of Pathology, March 1997.
  7. Rady P, Hodak E, Hudnall SD, Trattner A, Feinmesser M, David M, Gaspari A, Yen A, Memar O, Tyring SK.  Detection of HHV-8 DNA in Kaposi’s sarcomas from immunosuppressed patients.  Intl AIDS Malignancy Conf, Bethesda MD, 1997.
  8. Hudnall SD, Rady P, Watson D, Orengo I, Bruce S, Tyring SK.  Seroprevalence of human herpes virus 8 in various Kaposi’s sarcoma risk groups in south Texas. Institute for Human Virology, Baltimore MD, Sept 1997.
  9. Rady P, Hudnall SD, Yen A, Hughes TK, Tyring SK.  Frequency of human herpesvirus 8 cellular homolog gene expression in Kaposi’s sarcoma and BCBL-1 cells.  Institute for Human Virology, Baltimore MD, Sept 1997.
  10. Rady PL, Yen A, Hudnall SD, Hughes TK, Tyring SK. Expression of human herpesvirus 8 cellular homolog genes in Kaposi’s sarcomas and BCBL-1 cell lines.  American Academy of Dermatology. Feb 1998.
  11. Hudnall SD, Rady PL, Yen A, Tyring SK. Effect of hydrocortisone treatment on human herpesvirus 8 viral DNA replication and gene expression in BCBL-1 cells.  1st Intl KSHV Meeting, UC Santa Cruz, CA. July 1998.
  12. Hudnall SD, Dang T, Rady P, Allison P.  HHV-8 seroprevalence and viremic status of adult blood donors and renal transplant patients from the southeast Texas region. 1st Intl KSHV Meeting, UC Santa Cruz, CA. July 1998.
  13. Hudnall SD, Rady PL, Yen A, Tyring SK.  In-vitro steroid induced activation of HHV-8. Institute for Human Virology, Baltimore MD, Aug 1998.
  14. Hudnall SD, Rady PL, Tyring SK, Fish JC. Serologic and molecular evidence of human herpesvirus 8 activation in renal transplant recipients.  Infect Disease & Host Defense Poster Session, UTMB, Nov 1998.
  15. Hudnall SD. Flow Cytometry and In-Situ Hybridization Core Facility. Infectious Disease & Host Defense Poster Session, UTMB, Nov 1998.
  16. Matalon RK, Tyring SK, Rady P, Hudnall SD, Vargas T, Nitowsky H, Kellner LH. Methylenetetrahydrofolate reductase: High incidence of mutation C677T in Ashkenazi Jewish population. Society for Pediatric Research, 1999.
  17. Hudnall SD, Rady PL, Allison P. HHV8 prevalence and genomic variation in adult blood donors from the Texas Gulf coast region. Institute for Human Virology, Baltimore MD, 1999 (JAIDS 21(1): A18, 1999).
  18. Ventura KG, Hudnall SD.  Statistically significant hematologic abnormalities in heterophile antibody positive and negative mono patients. CAP-ASCP Conf. New Orleans, LA.  Nov 1999.
  19. Cao S, Hudnall SD, Lu LJ. Downregulation of estrogen receptor by phytoestrogens daidzein and genistein in MCF-7 breast cancer cells. AACR, 2000.
  20. Hudnall SD, Chen T, Al-Salameh A. Human herpesvirus 8 in acute tonsillitis and tonsillar hyperplasia. U.S.-Can. Academy of Pathology, New Orleans LA, March 2000.
  21. Stuart CA, Wen G, Peng B, Popov VL, Hudnall SD, Campbell GA. Contributions from T-tubules and peripheral nerves to human muscle GLUT3. Am Diabetes Assoc, 2000.
  22. Popnikolov NK, Payne DA, Hudnall SD, Hawkins HK, Kumar M, Elghetany MT.  CD13 positive anaplastic large cell lymphoma of T-cell origin:  A diagnostic and histogenetic problem.  Texas Society of Pathologists, Houston TX, Feb 2000.
  23. Walling DM, Flaitz CM, Nichols CM, Hudnall SD.  Non-lytic productive EBV replication in normal tongue epithelial cells in vivo. 9th Intl EBV Assoc, New Haven CT, June 2000.
  24. Hudnall SD, Chen T, Rady P, Tyring S, Allison P. HHV-8 seroprevalence and viral load in adult blood donors from southeast Texas. 9th Intl EBV Assoc, New Haven, June 2000
  25. Hudnall SD. The histopathology of EBV and HHV-8 associated diseases. 9th Intl EBV Assoc, New Haven CT, June 2000.
  26. Hudnall SD, Chen T, Rady P, Tyring S, Allison P. Low HHV-8 seroprevalence and absent blood-borne virus in adult blood donors from the Texas Gulf Coast. 3rd International Workshop on Kaposi’s Sarcoma Associated Herpesvirus, Amherst, MA, Jul 2000.   
  27. Rady PL, Tyring SK, Hudnall SD.  Increased expression of human herpesvirus 8 vGCR in AIDS-associated Kaposi’s Sarcoma.  2nd International Mortiz Kaposi Research Foundation Conf, Budapest, Hungary, Aug 2000.
  28. Hudnall SD, Chen T, Patel J, Martinez J, Schwab H. A detailed flow immunophenotype of atypical lymphocytosis in infectious mononucleosis. USCAP Annual Meeting, Atlanta, GA, March 2001.
  29. Wang S, Hudnall SD.  Differences in lymphocyte subsets in nodular sclerosis Hodgkin’s disease, mixed cellularity Hodgkin’s disease, and reactive lymphoid hyperplasia: A flow cytometric study. ASCP/CAP Fall Annual Meeting, Philadelphia, PA, October 2001.
  30. Cinclair R, Daller JA, Rice J, Hudnall SD, Agraharkar M.  Hypovolemic hyponatremia from unusual neoplasia.  Finalist, Clinical Vignette Competition, American College of Physicians – American Society of Internal Medicine Annual Meeting, Philadelphia PA, April 13, 2002.
  31. Wang L, Hudnall SD.  CD8 T cell lymphocytosis and stem cell depletion in HIV-1 positive marrow biopsies: correlation with anemia and thrombocytopenia. USCAP Annual Meeting, Washington DC, Feb 2003.
  32. Molina CP, Hudnall SD.  Comparison of the inflammatory infiltrates of endemic African and epidemic AIDS-associated Kaposi’s sarcoma. USCAP Annual Meeting, Washington DC, Feb 2003.
  33. Gokhale S, Hudnall SD. Lack of correlation between CD38 expression and hematologic parameters in chronic lymphocytic leukemia. Pan-Pacific Lymphoma Conference, Hawaii, July 2003.
  34. Wang S, Hudnall SD. Immunophenotype of the reactive lymphoid infiltrate of Hodgkin’s lymphoma: a flow cytometry study. Pan-Pacific Lymphoma Conference, Hawaii, July 2003.
  35. Ge Y, Hudnall SD.  Distribution of Epstein Barr virus in human tonsils.  USCAP Annual Meeting, Stowell-Orbison Competition, Vancouver, BC, March 2004.
  36. Hudnall SD, Chen T. Complete Whole Body Mapping of Tissue Reservoirs of Human Herpesvirus Infection with a Pan-Herpes PCR Technique. Platform presentation, USCAP Annual Meeting, San Antonio, Feb 2005.
  37. Hudnall SD, Chen T, Jackson S, Sanchez R. Detection of Human Herpesviruses in Pityriasis Rosea Skin Biopsies. USCAP Annual Meeting, Atlanta, Feb 2006.
  38. Hudnall SD, Chen T, Amr S, Henry K. Detection of Human Herpesviruses in Kikuchi-Fujimoto Lymphadenitis. USCAP Annual Meeting, Atlanta, Feb 2006.
  39. Velagaleti G, Northup J, Suleman K, Panova N, Hudnall SD. Detection of Philadelphia chromosome (Ph) in a patient with no evidence of leukemia: Further evidence of a changing paradigm? Am Soc Human Genetics, New Orleans, 2006.
  40. Shuttlesworth J, Hudnall SD. Uninvolved Staging Bone Marrow Abnormalities in Classic Hodgkin Lymphoma with Hematologic Correlation. Texas Society of Pathologists. January 2007.
  41. Betancourt E, Patel J, Barnhart E, Hudnall SD. Comparative Flow Immunophenotype of Hodgkin Lymphoma and Lymphoid Hyperplasia. Texas Society of Pathologists. January 2007.  3rd Prize.
  42. Millington K, Hudnall SD, Northup J, Panova N, Velagaleti G. Role of chromosome 1 pericentric heterochromatin (1q12) in pathogenesis of myelodysplastic syndromes. Texas Society of Pathologists. January 2007.
  43. Wahbah M, Shuttlesworth J, Northup J, Panova N, Elghetany T, Hudnall SD, Velagaleti G. Two-hit hypothesis revisited: origin of cytogenetically abnormal cells in histologically normal bone marrows of cancer patients. Texas Society of Pathologists. January 2007.
  44. Barnhart E, Hudnall SD. Regulatory and cytotoxic T cell subsets in Hodgkin lymphoma. Stowell-Orbison Competition, USCAP, San Diego, March 2007.
  45. Shuttlesworth J, Hudnall SD. Uninvolved staging bone marrow abnormalities in classic Hodgkin Lymphoma with hematologic correlation. ASCP Annual Meeting. October 2007.
  46. Perez M, Patel J, Hudnall SD. Immunophenotypic differences of tumor-infiltrating T cells in subtypes of B cell lymphoma. USCAP. Denver, March 2008.
  47. Hudnall SD, Crim J, Patel J, Giddings K, Martinez J. Abnormal immunophenotypic profile of reactive T cells in chronic lymphocytic leukemia. Clinical Cytometry Society. Portland, October 2008.
  48. Hudnall SD, Chen T, Barnhart E, Konig R. Inflammatory cytokine genes in Hodgkin lymphoma. USCAP Platform Presentation, Boston, March 2009.
  49. Siddon A, Lozavatsky L, Mohamed A, Hudnall SD. HHV-6 positive Reed-Sternberg cells in nodular sclerosis Hodgkin lymphoma. USCAP, Vancouver, March 2012.
  50. Czader M, Chiu A, Perkins SL, et al. Core needle biopsy in lymphoma diagnosis: a multi-institutional study. USCAP, San Diego, March 2014.

 

 

Stanley David Hudnall

Professor

  • DEPARTMENTDepartment of Pathology & Laboratory Medicine
    Yale University
  • COUNTRY USA